GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lotus Pharmaceutical Co Ltd (TPE:1795) » Definitions » E10

Lotus Pharmaceutical Co (TPE:1795) E10 : NT$6.32 (As of Dec. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Lotus Pharmaceutical Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Lotus Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2024 was NT$4.270. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is NT$6.32 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Lotus Pharmaceutical Co's average E10 Growth Rate was 60.00% per year. During the past 3 years, the average E10 Growth Rate was 134.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Lotus Pharmaceutical Co was 134.50% per year. The lowest was 134.50% per year. And the median was 134.50% per year.

As of today (2025-03-23), Lotus Pharmaceutical Co's current stock price is NT$253.50. Lotus Pharmaceutical Co's E10 for the quarter that ended in Dec. 2024 was NT$6.32. Lotus Pharmaceutical Co's Shiller PE Ratio of today is 40.11.

During the past 13 years, the highest Shiller PE Ratio of Lotus Pharmaceutical Co was 4745.00. The lowest was 40.27. And the median was 93.98.


Lotus Pharmaceutical Co E10 Historical Data

The historical data trend for Lotus Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lotus Pharmaceutical Co E10 Chart

Lotus Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.16 0.49 2.24 3.95 6.32

Lotus Pharmaceutical Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.95 4.56 5.11 5.78 6.32

Competitive Comparison of Lotus Pharmaceutical Co's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Lotus Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lotus Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lotus Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Lotus Pharmaceutical Co's Shiller PE Ratio falls into.



Lotus Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Lotus Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=4.27/133.1571*133.1571
=4.270

Current CPI (Dec. 2024) = 133.1571.

Lotus Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201503 -0.130 99.621 -0.174
201506 0.370 100.684 0.489
201509 0.060 100.392 0.080
201512 0.125 99.792 0.167
201603 0.270 100.470 0.358
201606 0.070 101.688 0.092
201609 -0.140 101.861 -0.183
201612 -0.766 101.863 -1.001
201703 -0.300 102.862 -0.388
201706 0.150 103.349 0.193
201709 0.200 104.136 0.256
201712 0.040 104.011 0.051
201803 0.070 105.290 0.089
201806 -0.230 106.317 -0.288
201809 0.280 106.507 0.350
201812 0.303 105.998 0.381
201903 1.160 107.251 1.440
201906 0.200 108.070 0.246
201909 0.820 108.329 1.008
201912 0.570 108.420 0.700
202003 0.540 108.902 0.660
202006 1.230 108.767 1.506
202009 1.150 109.815 1.394
202012 1.300 109.897 1.575
202103 1.840 111.754 2.192
202106 1.380 114.631 1.603
202109 1.330 115.734 1.530
202112 0.950 117.630 1.075
202203 1.710 121.301 1.877
202206 1.250 125.017 1.331
202209 7.930 125.227 8.432
202212 0.630 125.222 0.670
202303 4.550 127.348 4.758
202306 4.840 128.729 5.007
202309 4.750 129.860 4.871
202312 1.510 129.419 1.554
202403 3.940 131.776 3.981
202406 5.060 132.554 5.083
202409 5.950 133.029 5.956
202412 4.270 133.157 4.270

Add all the adjusted EPS together and divide 10 will get our e10.


Lotus Pharmaceutical Co  (TPE:1795) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Lotus Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=253.50/6.32
=40.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Lotus Pharmaceutical Co was 4745.00. The lowest was 40.27. And the median was 93.98.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Lotus Pharmaceutical Co E10 Related Terms

Thank you for viewing the detailed overview of Lotus Pharmaceutical Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Lotus Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Song Ren Road, 17th Floor, No. 277, Xin Yi District, Taipei, TWN, 110
Lotus Pharmaceutical Co Ltd is engaged in the healthcare sector. The only reportable segment of the company is the Pharmaceuticals business segment, which engages mainly in the research and development, manufacturing and sales of pharmaceutical products. It has a geographic presence in the United States, Malta, Taiwan, and Others.

Lotus Pharmaceutical Co Headlines

No Headlines